Memo Therapeutics AG FEATURED AT ESMO CONFERENCE IN LAUSANNE, SWITZERLAND

Memo Therapeutics AG’s poster introducing the MemoMAB™ technology platform for the banking and screening of human immunoreceptor libraries was selected for the Poster Discussion Session at this fall’s European Society of Medical Oncology (ESMO) Symposium on Immuno-Oncology in Lausanne.

To be featured at this prestigious venue provided Memo Therapeutics AG with an outstanding visibility within the academic clinical community and among pharma players active in the field of Immuno-Oncology.